UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000003347
Receipt No. R000004065
Scientific Title Beneficial effects of foot care nursing for people with diabetes mellitus: An uncontrolled before and after intervention.
Date of disclosure of the study information 2010/12/24
Last modified on 2020/09/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Beneficial effects of foot care nursing for people with diabetes mellitus: An uncontrolled before and after intervention.
Acronym effects of foot care nursing for people with diabetes mellitus
Scientific Title Beneficial effects of foot care nursing for people with diabetes mellitus: An uncontrolled before and after intervention.
Scientific Title:Acronym effects of foot care nursing for people with diabetes mellitus
Region
Japan

Condition
Condition diabetes mellitus
Classification by specialty
Endocrinology and Metabolism Nursing
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We develope a nurse-based diabetic foot care program based on the International Working Group on the Diabetic Foot. The aim of present study is to investigate the effectiveness of foot care nursing in preventing diabetic foot ulceration.
Basic objectives2 Others
Basic objectives -Others We are divided into patients 0 to 3 risk groups according to the IWGDF risk classification.During the 2-year program, each patient received 30-60 min foot care, once a year to once every 1-6 months depending on the risk category. We evaluate the incidence of foot ulceration or recurrence and non-ulcerated foot condition.
Trial characteristics_1
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes We evaluate the incidence of diabetic foot ulceration or recurrence and non-ulcerated foot (callus and tinea pedes) condition.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 We are divided into patients 0 to 3 risk groups according to the IWGDF risk classification.During the 2-year program, each patient received 30-60 min foot care, once a year to once every 1-6 months depending on the risk category. We evaluate the incidence of foot ulceration or recurrence and non-ulcerated foot condition.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients are refered to diabetes care unit from outpatient clinic of the endocrinology at Osaka University Hospital.Among that patients who attend our foot care program for 2 consecutive years.
Key exclusion criteria We excluded those patients with orthopedic diseases, cranial nerve disorders, impaired cognitive function, mental disorders, and those on chemotherapy. We also excluded those who did not adhere to our 2-year program.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Iichiro Shimomura
Organization Graduate School of Medicine, Osaka University
Division name Department of Metabolic Medicine
Zip code
Address 2-2-B5, Yamada-oka, Suita, Osaka, 565-0871, Japan
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name Yuko Fujiwara
Organization Osaka University Hospital
Division name Diabetes Care Unit
Zip code
Address 2-15, Yamada-oka, Suita, Osaka, 565-0871, Japan
TEL 06-6879-5391
Homepage URL
Email f_yuko@hosp.med.osaka-u.ac.jp

Sponsor
Institute Diabetes Care Unit and Department of Metabolic Medicine, Osaka University Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2010 Year 12 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2009 Year 05 Month 25 Day
Date of IRB
2009 Year 05 Month 25 Day
Anticipated trial start date
2009 Year 06 Month 01 Day
Last follow-up date
2011 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2010 Year 03 Month 17 Day
Last modified on
2020 Year 09 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004065

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.